ANC-501

· Ancora Bio, Inc. d/b/a EmbarkNeuro

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANC-501, covering 2024-12-31 to 2024-12-31. Get the full timeline:

Most recent: Clinical Trial Update: ANC-501 in the Treatment of Adults With Major Depressive Disorder [Phase 2]